Login / Signup

Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.

Claire BridelCyra E LeursZoë Y G J van LieropZoé L E van KempenIris DekkerHarry A M TwaalfhovenBastiaan MoraalFrederik BarkhofBernard M J UitdehaagJoep KillesteinCharlotte E Teunissen
Published in: Neurology (2021)
This study provides Class II evidence that serum NfL levels are not associated with disease progression in natalizumab-treated patients with RRMS.
Keyphrases
  • multiple sclerosis
  • white matter
  • newly diagnosed
  • rheumatoid arthritis
  • disease activity